HemAware

Featured On HemAware

Why Has Gene Therapy for Hemophilia Been Slow to Catch On?

After years of excitement about a possible “one-and-done” treatment, gene therapy uptake has been slower than expected. Here’s why.
Read More

Why Has Gene Therapy for Hemophilia Been Slow to Catch On?
What Are Biosimilars? A Guide for People with Bleeding Disorders

Similar to biologic medications, this type of therapy is safe and effective and could expand your access to treatment.
Read More
OhmBody: A New Approach to Therapy for Heavy Menstrual Bleeding

The wearable wellness device works without medications or hormones and complements other bleeding disorder treatments.
Read More

In a rapidly changing hemophilia treatment landscape, shared decision-making helps patients and providers choose the option that fits best.

Taking Charge, Hemophilia A&B

It took years for Julie Schiffmacher to be diagnosed with von Willebrand disease. Now she’s turning that experience into advocacy.

My Journey

These two bleeding disorders share some similarities but are also unique in significant ways. Here’s what you need to know.

Hemophilia A&B, Von Willebrand Disease

HemAware asked parents for their best advice on what has helped them navigate their children’s bleeding disorders in the first...

Family Matters

Recently, HemAware received a question for our “Ask a Social Worker” column about having an abortion if you have a...

Ask a Social Worker is a monthly column featuring questions from the community and answers from members of NHF’s Social...

Women's Bleeding Disorders, Ask a Social Worker

Unfortunately, people with hemophilia are no strangers to pain and its many forms. Pain can vary in intensity and areas...

Pain Management

Need Information about Bleeding Disorders?

Contact The Neil Frick Resource Center (NFRC)